On Tuesday, Indaptus Therapeutics Inc (NASDAQ: INDP) was -3.94% drop from the session before settling in for the closing price of $2.03. A 52-week range for INDP has been $1.65 – $47.60.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 57.27%. When this article was written, the company’s average yearly earnings per share was at 53.88%. With a float of $1.69 million, this company’s outstanding shares have now reached $1.75 million.
Considering the fact that the conglomerate employs 7 people, you should pay attention to its efficiency factor.
Indaptus Therapeutics Inc (INDP) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Indaptus Therapeutics Inc stocks. The insider ownership of Indaptus Therapeutics Inc is 3.55%, while institutional ownership is 4.02%.
Indaptus Therapeutics Inc (INDP) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -10.64 earnings per share (EPS) during the time that was better than consensus figure (set at -11.48) by 0.84. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.87 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.88% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 53.89% during the next five years compared to 57.27% growth over the previous five years of trading.
Indaptus Therapeutics Inc (NASDAQ: INDP) Trading Performance Indicators
You can see what Indaptus Therapeutics Inc (INDP) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -31.51, a number that is poised to hit -4.36 in the next quarter and is forecasted to reach -6.34 in one year’s time.
Technical Analysis of Indaptus Therapeutics Inc (INDP)
Compared to the last year’s volume of 0.23 million, its volume of 1.01 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 4.13%.
During the past 100 days, Indaptus Therapeutics Inc’s (INDP) raw stochastic average was set at 4.26%, which indicates a significant increase from 2.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.20 in the past 14 days, which was lower than the 0.52 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.69, while its 200-day Moving Average is $8.30. Nevertheless, the first resistance level for the watch stands at $2.03 in the near term. At $2.10, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.15. If the price goes on to break the first support level at $1.90, it is likely to go to the next support level at $1.85. Now, if the price goes above the second support level, the third support stands at $1.77.
Indaptus Therapeutics Inc (NASDAQ: INDP) Key Stats
There are 1,751K outstanding shares of the company, which has a market capitalization of 3.41 million. As of now, sales total 0 K while income totals -15,020 K. Its latest quarter income was 0 K while its last quarter net income were -2,980 K.
